6505-01-386-7692 ( NDC00019-5505-08 , 550508 , HEXABRIX )
NSN Information
| NSN | FSC | NIIN | Item Name | INC |
|---|---|---|---|---|
| 6505-01-386-7692 | 6505 | 013867692 | IOXAGLATE MEGLUMINE AND IOXAGLAT | 6656 |
NSN Features
| MRC | Parameter | Characteristics |
|---|---|---|
| AKJA | ACTIVE MEDICAMENT MEDICINAL STRENGTH | 39.300 PERCENTAGE, W/V IOXAGLATE MEGLUMINE ACTIVE INGREDIENT AND 19.600 PERCENTAGE, W/V IOXAGLATE SODIUM ACTIVE INGREDIENT |
| FEAT | SPECIAL FEATURES | 320 MGI/ML |
| CSCW | TOTAL PRIMARY CONTAINER QUANTITY | 12 |
| CQCT | PRIMARY CONTAINER TYPE | BOTTLE |
| CRLK | PRIMARY CONTAINER CONTENT QUANTITY | 100.000 MILLILITERS |
Manufacturing Part Numbers (SKUs)
| Part SKU | Cage | Status | RNVC | RNCC | SADC | DAC | RNAAC |
|---|---|---|---|---|---|---|---|
| NDC00019-5505-08 | 2A916 | A | 2 | 3 | 4 | ZZ | |
| 550508 | 2A916 | A | 1 | 5 | 4 | ZZ | |
| HEXABRIX | 2A916 | A | 1 | 5 | 4 | ZZ |
Manufacturers
| Part SKU | Cage | Manufacturer | Type | Status |
|---|---|---|---|---|
| NDC00019-5505-08 | 2A916 | MALLINCKRODT DIAGNOSTICS | F | A |
| 550508 | 2A916 | MALLINCKRODT DIAGNOSTICS | F | A |
| HEXABRIX | 2A916 | MALLINCKRODT DIAGNOSTICS | F | A |
FLIS Identification
| PMIC | ADPE Code | CRITL Code | DEMIL Code | DEMIL INTG | NIIN Asgt | ESD | HMIC | ENAC | Schedule-B | INC |
|---|---|---|---|---|---|---|---|---|---|---|
| A | X | A | 1 | 02/15/1 | Y | 3006300000 | 6656 |
FLIS Management
| MOE | REC Rep Code | Mgmt Ctl | USC | Phrase Code | Phrase Statement |
|---|---|---|---|---|---|
| VA | V | K | U/I CONTAINS 12 EA |
Demilitarization Codes & Management
| DML | PMI | HMIC | ADP | CC | ESDC |
|---|---|---|---|---|---|
| A | A | Y | X |
Miscellaneous Management
| MOE (S_A) | SOS | AAC | QUP | UI | SLC | CIIC | RC | MCC | SVC |
|---|---|---|---|---|---|---|---|---|---|
| VA | I | 0 | PG | M | U | V |
Management Control Army
| MATCAT 1 | MATCAT 2 | MATCAT 3 | MATCAT 4 5 | ARC |
|---|
Freight
| NMFC | NMFC SUB | UFC | HMC | LTL | LCL | WCC | TCC | SHC | ADC | ACC | ASH | NMF DESC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|